Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 488 participants.

Also called NCT07469293

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 488 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07469293
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07469293. Randomized; no masking; primary purpose treatment. Start 2026-03-25 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)
Condition
Acute Ischemic Stroke
Intervention (Procedure)
Intra-arterial thrombolysis
Intervention (Other)
Standard medical treatment
Lead sponsor
Southwest Hospital, China (class: other)

Record details

Record id
cardio:ct-nct07469293
Content hash
c41275cfbd9625b81508a9a62da88ec2661e511ab83ff1012a8ac90c7f9d8ae4